Gross Profit Margin (Quarterly) Chart

Historical Gross Profit Margin (Quarterly) Data

View and export this data back to 2003. Start Trial.
Date Value
June 30, 2026 51.92%
March 31, 2026 40.44%
December 31, 2025 27.00%
September 30, 2025 42.74%
June 30, 2025 42.26%
March 31, 2025 33.20%
December 31, 2024 -449.5%
September 30, 2024 -619.0%
June 30, 2024 -332.7%
March 31, 2024 -653.7%
December 31, 2023 -1.60K%
September 30, 2023 -1.48K%
June 30, 2023 -2.17K%
March 31, 2023 -4.42K%
December 31, 2022 -3.67K%
September 30, 2022 -5.57K%
June 30, 2022 -4.34K%
March 31, 2022 -4.15K%
December 31, 2021 -3.22K%
September 30, 2021 -2.83K%
June 30, 2021 -5.32K%
March 31, 2021 -4.90K%
December 31, 2020 40.61%
September 30, 2020 40.15%
June 30, 2020 48.21%
Date Value
March 31, 2020 39.73%
December 31, 2019 -128.5%
September 30, 2019 99.24%
June 30, 2019 50.76%
March 31, 2019 52.39%
December 31, 2018 84.29%
September 30, 2018 50.76%
June 30, 2018 50.92%
March 31, 2018 51.00%
December 31, 2017 51.04%
September 30, 2017 51.20%
June 30, 2017 51.40%
March 31, 2017 51.41%
December 31, 2016 82.50%
September 30, 2016 49.44%
June 30, 2016 49.88%
March 31, 2016 49.25%
December 31, 2015 52.95%
September 30, 2015 48.58%
June 30, 2015 68.06%
March 31, 2015 55.70%
December 31, 2014 93.25%
September 30, 2014 61.86%
June 30, 2014 56.04%
March 31, 2014 67.03%

Gross Profit Margin Definition

Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.

Read full definition.

Gross Profit Margin (Quarterly) Range, Past 5 Years

View Gross Profit Margin (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Gross Profit Margin (Quarterly) Benchmarks

View Gross Profit Margin (Quarterly) Benchmarks
Start Trial
3-D Matrix Ltd. 80.07%
Healios KK -886.3%
GNI Group Ltd. 71.81%
Agenus, Inc. 98.50%
Amgen, Inc. 72.08%

Gross Profit Margin (Quarterly) Related Metrics